-Wednesday 4 November 2015

16.30 – 18.30

Welcome Symposium – Primary Immunodeficiency: a 70-Year Journey, Striving for Optimisation, Flexibility and Perfection in Daily Patient Care (Sponsored by Octapharma)Chair: Prof Hans Ochs

A Journey from Bruton’s Syndrome to Modern Agammaglobulinemia Overview of Historical Diagnosis & Treatment Options – Prof Hans Ochs

The Evolution of PID Classification & Definition of Subjects in Need of Regular Immune Antibody Substitution Therapy – Prof Helen Chapel

PID Homecare Based on Subcutaneously Administered Highly Concentrated Immunoglobulins & How it Impact Quality of Life – Prof Ann Gardulf

In a Developing World of Novel 10% Intravenous Immunoglobulin Products, the Original 5% Solutions Still Have an Important Role & Why – Dr Isaac Melamed.

-Thursday 5 November 2015

16.00 – 17.30

Scientific Symposium 1 – The Importance of safe and effective immunoglobulin therapies: Global perspectives (Sponsored by Biotest)Chair: Prof Bodo Grimbacher

Quality and Safety of Immunoglobulin Therapies – Dr Jacqueline Kerr and Dr Nanette Gross (invited and sponsored by IPOPI)

Diagnosis and therapy of PIDs (current aspects) European perspective – Dr Klaus Warnatz

Diagnosis and therapy of PIDs (current aspects) Developing world perspective – Prof Lokman Noh

Panel Discussion

– Friday 6 November 2015

12.30 – 14.00

Lunch Symposium – Advanced Care in Primary Immunodeficiencies: from birth to adulthood (Sponsored by LFB)Chair: Prof Nizar Mahlaoui

Have the diagnostic discoveries improved the management of PID patients? Review and future perspectives – Dr Klaus Warnatz

What improvements does the therapeutic management make? Future perspectives – Prof Andrew Cant

Transition care: from childhood to adulthood – Dr Allison Jones & Nurse Sarita Workman